Skip to main content
Signal8
Launch Terminal
Andrle Edward profile photo

Edward Andrle

CIK: 0001656026

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NEUROONE MEDICAL TECHNOLOGIES Corp logo
NMTC

NEUROONE MEDICAL TECHNOLOGIES Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • NEUROONE MEDICAL TECHNOLOGIES Corp logo
    NMTC

    NEUROONE MEDICAL TECHNOLOGIES Corp

    Apr 3, 2026
    Award(A)
    Direct
    41.9K shares-
  • NEUROONE MEDICAL TECHNOLOGIES Corp logo
    NMTC

    NEUROONE MEDICAL TECHNOLOGIES Corp

    Jun 23, 2025
    Award(A)

    Option to Purchase Common Stock

    Direct
    50K shares-
  • NEUROONE MEDICAL TECHNOLOGIES Corp logo
    NMTC

    NEUROONE MEDICAL TECHNOLOGIES Corp

    Feb 14, 2025
    Award(A)
    Direct
    27.8K shares-

1-3 of 3

About Andrle Edward

Andrle Edward (SEC CIK 0001656026) files insider reports with the SEC as Director of NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC).

Signal8 holds 3 ownership filings by Andrle Edward, all Form 4s, filed between Feb 19, 2025 and Apr 7, 2026. Those filings report 3 transactions, from Feb 14, 2025 to Apr 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Andrle Edward's filings is in EDEN PRAIRIE, MN.

Recent filings by Andrle Edward

  • Apr 3, 2026: Grant or award of NMTC shares (Form 4, code A).
  • Jun 23, 2025: Grant or award of NMTC derivative securities (Form 4, code A).
  • Feb 14, 2025: Grant or award of NMTC shares (Form 4, code A).

Other insiders filing for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

How to read Form 4 transaction codes